Division of Molecular Genetic Epidemiology, German Cancer Research Centre, DKFZ, Heidelberg, Germany.
Int J Cancer. 2013 Feb 15;132(4):944-50. doi: 10.1002/ijc.27678. Epub 2012 Jul 21.
Cancer of unknown primary site (CUP) is a fatal cancer ranking among the five most common cancer deaths. CUP is diagnosed through metastases, which are limited to lymph nodes in some patients. Cause-specific survival data could guide the search for hidden primary tumors and help with therapeutic choices. The CUP patients were identified from the Swedish Cancer Registry between 1987 and 2008; 1,444 patients had only lymph node metastasis of defined histology (adenocarcinoma, squamous cell or undifferentiated). Site-specific cancer deaths were analyzed by lymph node location and histology. Kaplan-Meier survival curves were compared with metastatic primary cancer at related sites. Among the patients with metastasis to head and neck lymph nodes, 117 (59.1% of the specific cancer deaths) died of lung tumors. Patients with axillary lymph node metastasis died of lung and breast tumors in equal proportions (40.2% each). Also, squamous cell CUP in head and neck lymph nodes was mainly associated with lung tumor deaths (53.1%). With a few exceptions, survival of CUP patients with lymph node metastasis was indistinguishable from survival of patients with metastatic primary cancer originating from the organs drained by those nodes. The association between lymph node CUP metastases with cancer deaths in the drained organ and the superimposable survival kinetics suggests that drained organs host hidden primaries. Importantly, half of all site-specific cancer deaths (266/530) were due to lung tumors. Thus, an intense search should be mounted to find lung cancer in CUP patients with lymph node metastases.
原发灶不明的癌症(CUP)是一种致命的癌症,在五种最常见的癌症死亡原因中排名第五。CUP 通过转移来诊断,一些患者的转移仅限于淋巴结。基于病因的生存数据可以指导对隐匿性原发肿瘤的寻找,并有助于治疗选择。1987 年至 2008 年间,从瑞典癌症登记处确定了 CUP 患者;1444 名患者仅有明确组织学的淋巴结转移(腺癌、鳞状细胞癌或未分化癌)。根据淋巴结位置和组织学对部位特异性癌症死亡进行了分析。Kaplan-Meier 生存曲线与相关部位的转移性原发性癌症进行了比较。在头颈部淋巴结转移的患者中,117 人(特定癌症死亡的 59.1%)死于肺癌。腋窝淋巴结转移的患者死于肺癌和乳腺癌的比例相等(各占 40.2%)。同样,头颈部淋巴结的鳞状细胞 CUP 主要与肺癌死亡有关(53.1%)。除了少数例外,有淋巴结转移的 CUP 患者的生存与源自这些淋巴结引流器官的转移性原发性癌症患者的生存无法区分。淋巴结 CUP 转移与引流器官癌症死亡之间的关联以及可叠加的生存动力学表明,引流器官存在隐匿性原发肿瘤。重要的是,所有部位特异性癌症死亡(266/530)的一半是由于肺癌。因此,应该对有淋巴结转移的 CUP 患者进行强烈的搜索,以寻找肺癌。